Stability of serum total and free prostate specific antigen under varying storage intervals and temperatures.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 9366340)

Published in J Urol on December 01, 1997

Authors

C G Arcangeli1, D S Smith, T L Ratliff, W J Catalona

Author Affiliations

1: Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

Articles by these authors

Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med (1991) 6.94

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol (1994) 5.31

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol (1992) 4.79

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA (1997) 4.56

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA (1993) 3.46

Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res (2001) 3.45

NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron (2000) 3.45

Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun (1988) 3.35

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol (1994) 3.17

Comparison of time-resolved and -unresolved measurements of deoxyhemoglobin in brain. Proc Natl Acad Sci U S A (1988) 3.01

Preemptive epidural analgesia and recovery from radical prostatectomy: a randomized controlled trial. JAMA (1998) 2.74

ECT-induced delirium in depressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci (1991) 2.70

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA (1995) 2.63

The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol (1988) 2.38

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol (1994) 2.25

Repeatability and validity of a modified activities of daily living (ADL) index in studies of chronic disability. Int Rehabil Med (1979) 2.14

Morphological evidence for the participation of microtubules in axonal transport. Ann N Y Acad Sci (1975) 2.13

The effectiveness of the confidential unit exclusion option. Transfusion (1994) 2.12

Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol (1999) 2.07

Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol (1995) 2.05

Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet (2001) 2.03

Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA (1996) 1.97

New concepts in acute pain therapy: preemptive analgesia. Am Fam Physician (2001) 1.97

Structural cross-bridges between microtubules and mitochondria in central axons of an insect (Periplaneta americana). J Cell Sci (1977) 1.97

Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol (1995) 1.94

Comparison of surgical and anesthetic complications in neurosurgical patients experiencing venous air embolism in the sitting position. Neurosurgery (1986) 1.92

Can I have an ambulance, doctor? Br Med J (1974) 1.90

A method for dinitrochlorobenzene contact sensitization. A clinicopathological study. N Engl J Med (1972) 1.88

On the significance of cross-bridges between microtubules and synaptic vesicles. Philos Trans R Soc Lond B Biol Sci (1971) 1.86

Remedial therapy after stroke: a randomised controlled trial. Br Med J (Clin Res Ed) (1981) 1.84

The organization of synaptic axcplasm in the lamprey (petromyzon marinus) central nervous system. J Cell Biol (1970) 1.83

Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J Urol (1994) 1.81

Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. J Urol (1998) 1.80

Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results. Alzheimer Dis Assoc Disord (1993) 1.72

Clinical use of prostate specific antigen in patients with prostate cancer. J Urol (1989) 1.71

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol (1996) 1.70

A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol (2000) 1.69

Alzheimer's disease and driving: prediction and assessment of driving performance. J Am Geriatr Soc (1997) 1.68

Parkinsonian symptoms during emergence from general anesthesia. Anesthesiology (1995) 1.65

Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol (1994) 1.63

Lower caliceal stone clearance after shock wave lithotripsy or ureteroscopy: the impact of lower pole radiographic anatomy. J Urol (1998) 1.63

Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy. Transfusion (1995) 1.59

The organization and myofilament array of insect visceral muscles. J Cell Sci (1966) 1.57

Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet (2000) 1.57

Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg (1997) 1.56

Short-wave infrared transfer radiometer for the calibration of the moderate-resolution imaging spectrometer and the advanced spaceborne thermal emission and reflection radiometer. Appl Opt (2000) 1.56

Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med (2001) 1.55

Development of a mouse model for nonbacterial prostatitis. J Urol (1994) 1.53

Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth. J Natl Cancer Inst (1997) 1.52

A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet (2000) 1.51

5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol (1994) 1.51

Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol (2000) 1.50

Oxidative phosphorylation system during steady-state hypoxia in the dog brain. J Appl Physiol (1985) (1990) 1.48

A Mycobacterium leprae gene encoding a fibronectin binding protein is used for efficient invasion of epithelial cells and Schwann cells. Infect Immun (1995) 1.46

The effect of oral midazolam on anxiety of preschool children during laceration repair. Ann Emerg Med (1990) 1.46

Estimating lumbar-puncture depth in children. N Engl J Med (1988) 1.45

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol (2000) 1.45

The organization and function of the sarcoplasmic reticulum and T-system of muscle cells. Prog Biophys Mol Biol (1966) 1.45

Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response. J Clin Invest (1990) 1.42

Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol (1998) 1.42

Acute preoperative hemodilution in patients undergoing radical prostatectomy: a case study analysis of efficacy. Anesth Analg (1994) 1.42

A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology (1999) 1.41

Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells. J Clin Invest (1993) 1.38

Expectant management and the natural history of localized prostate cancer. J Urol (1994) 1.38

Antegrade approach to radical retropubic prostatectomy in patients with difficult apical dissection. J Urol (1991) 1.38

Radical surgery for advanced prostate cancer and for radiation failures. J Urol (1992) 1.38

Biochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failed. Urology (1998) 1.38

Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol (1987) 1.38

Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. Hum Pathol (2001) 1.37

Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol (2000) 1.36

Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature (1993) 1.35

Translational control of ribosomal protein L4 mRNA is required for rapid neurite regeneration. Neurobiol Dis (2000) 1.35

Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer (2000) 1.34

Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer (2000) 1.34

Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage. Cancer (1973) 1.33

Requirement of a thymus dependent immune response for BCG-mediated antitumor activity. J Urol (1987) 1.33

Corticosteroids in croup: a chink in the ivory tower? J Pediatr (1989) 1.31

Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin. Cancer Res (1987) 1.28

Polarisation fluoroimmunoassay of gentamicin. Clin Chim Acta (1976) 1.27

Characterization of the fibronectin-attachment protein of Mycobacterium avium reveals a fibronectin-binding motif conserved among mycobacteria. Mol Microbiol (1996) 1.27

Assessment of motor function in studies of chronic disability. Rheumatol Rehabil (1980) 1.27

Exocytosis in the adrenal medulla demonstrated by freeze-etching. Science (1973) 1.25

Five-year experience in prehospital intraosseous infusions in children and adults. Ann Emerg Med (1993) 1.25

The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience. Cancer (1997) 1.25

Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol (1997) 1.24

T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. J Urol (1993) 1.24

Endocrine therapy for bladder outlet obstruction from carcinoma of the prostate. J Urol (1985) 1.24

Adult endopyelotomy: impact of etiology and antegrade versus retrograde approach on outcome. J Urol (1998) 1.24

Endothelial projections as revealed by scanning electron microscopy. Science (1971) 1.24

Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology (1993) 1.23